[1] 高晓津, 杨进刚, 杨跃进, 等. 中国急性心肌梗死患者心血管危险因素分析[J]. 中国循环杂志, 2015(3): 206-210.
[2] Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction [J]. Cardiovascular Research, 2009, 81: 457-464.
[3] Liu S, Yin T, Wei X, et al. Downregulation of adiponectin induced by tumor necrosis factor alpha is involved in the aggravation of post traumatic myocardial ischemia/reperfusion
injury [J]. Crit Care Med, 2011, 9: 1935-1943.
[4] Turer A T, Hill J A. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy [J]. Am J Cardiol, 2010, 106: 360-368.
[5] Yun B, Lee H, Ghosh M, et al. Serine hydrolase inhibitors block necrotic cell death by preventing calcium overload of the mitochondria and permeability transition pore formation [J]. J Biol Chem, 2014, 289: 1491-1504.
[6] Frangogiannis N G. Targeting the inflammatory response in healing myocardial infarcts [J]. Curr Med Chem, 2006, 13: 1877-1893.
[7] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病杂志, 2010, 38: 675-690.
[8] Henry T D, Atkins J M, Cunningham M S, et al. ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction? [J]. J Am Coll Cardiol, 2006, 47: 1339-1345.
[9] Li J, Yang P, Li A, et al. Cardioprotective effect of liposomal prostaglandin E1 on a porcine model of myocardial infarction reperfusion no-reflow [J]. J Zhejiang Univ-Sci B: Biomed &
Biotechnol, 2011, 12: 638-643.
[10] Enrique M S, James H T, Noelia C, et al. Beneficial effects of intra-arterial and intravenous prostaglandin E1 in intestinal ischaemia—reperfusion injury [J]. Interact Cardiovasc Thorac Surg, 2014, 18: 466-474.
[11] Hsieh C C, Hsieh S H, Chiu J H, et al. Protective effects of n-acetylcysteine and a prostaglandin E1 analog, alprostadil, against hepatic ischemia: reperfusion injury in rats [J]. J Tradit Complement Med, 2014, 4: 64-71.
|